openPR Logo
Press release

Left Appendage Occlusion Device Market Size Soars: Projected 21.2% CAGR Growth by 2031

06-23-2024 04:45 PM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Left Appendage Occlusion Device Market Size Soars: Projected

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Left Appendage Occlusion Device Market- by Brand (Sierra, AtriClip, WaveCrest, Amplatzer Amulet, WATCHMAN, Ultrasept, LAmbre, and LARIAT), Distribution Channel (Hospitals, Ambulatory Surgical Centers, and Heart Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1095

According to the latest research by InsightAce Analytic, the global Left Appendage Occlusion Device market is valued at US$ 960.0 Million in 2022, and it is expected to reach US$ 5381.3 Million by 2031, with a CAGR of 21.2 % during a forecast period of 2024-2031.

The left appendage occlusion device is utilised in procedures like thoracoscopic left atrial appendage closure and percutaneous transluminal left atrial appendage occlusion. The electrical impulses during atrial fibrillation are controlled with a left appendage occlusion device. Blood clots are expelled from the heart during atrial fibrillation. In the atria and LAA, this blood can clot. A stroke may result from this medical condition. The left appendage occlusion device is an interventional tool used to prevent stroke in atrial fibrillation. Adopting a left appendage occlusion device lowers the chance of subsequent stroke and emboli due to atrial fibrillation.

Over the course of the forecast period, the left appendage occlusion device market is anticipated to expand quickly. Growing instances of atrial fibrillation are anticipated to increase demand for left appendage occlusion devices and accelerate market expansion. Increased consumer awareness, new product releases in foreign markets, and clinical evidence of the effectiveness of left appendage occlusion devices compared to mainstream therapeutic treatments like warfarin and dabigatran are significant factors driving the market expansion. However, the necessity for skilled surgeons and the challenging implantation procedures limit the industry's constraints. Introducing new products is hampered by the strict regulatory requirements for device approval.
North America is anticipated to be the major contributor to the Left Appendage Occlusion Device market over the forecast years. In order to reduce the burden of the conditions, there are strong medical technology businesses, CDMOs for medical equipment, and even strong backing from the federal government.

Atrial fibrillation is becoming more common, and the Left Appendage Occlusion Device offers many benefits, which are some of the known drivers driving the market. In addition, the Asia Pacific Left Appendage Occlusion Device market is expected to grow significantly during the forecast period. The market is being driven by both technological advancements and an increase in the prevalence of atrial fibrillation in the elderly population. Cardiovascular diseases that result in heart attacks are more common in people over 65. Strong demand for these devices is anticipated over the projection period as a result. A surge in government initiatives to raise public awareness about cardiovascular illnesses is also helping to boost the industry.

Major market players operating in the Left Appendage Occlusion Device market include Atricure, Boston Scientific, Biosense Webster, Abbott Laboratories, Aegis Medical, Cardia, Lifetech Scientific, and Sentreheart.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1095

Recent collaborations and agreements in the market:
• In August 2021, the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder manufactured by Abbott Laboratories was given FDA approval in the United States. The purpose of these devices is to treat atrial fibrillation. This approval will help the business increase product sales and take a significant market share in the United States.
• In July 2020, the FDA in the United States approved Boston Scientific Corporation's WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device. This approval helped the business improve the left atrial appendage closure devices it offered, giving it a competitive edge in the market.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1095

Market Segments
Global Left Appendage Occlusion Device Market, by Brand, 2024-2031 (Value US$ Mn)
• Sierra
• AtriClip
• WaveCrest
• Amplatzer Amulet
• WATCHMAN
• Ultrasept
• LAmbre
• LARIAT

Global Left Appendage Occlusion Device Market, by Distribution Channel, 2024-2031 (Value US$ Mn)
• Hospitals
• Ambulatory Surgical Centers
• Heart Clinics

Global Left Appendage Occlusion Device Market, by Region, 2024-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Left Appendage Occlusion Device Market, by Country, 2024-2031 (Value US$ Mn)
• U.S.
• Canada

Europe Left Appendage Occlusion Device Market, by Country, 2024-2031 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Left Appendage Occlusion Device Market, by Country, 2024-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Left Appendage Occlusion Device Market, by Country, 2024-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Left Appendage Occlusion Device Market, by Country, 2024-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Left Appendage Occlusion Device market
 To receive an industry overview and future trends of the Left Appendage Occlusion Device market
 To analyze the Left Appendage Occlusion Device market drivers and challenges
 To get information on the Left Appendage Occlusion Device market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Left Appendage Occlusion Device market industry

For More Customization @ https://www.insightaceanalytic.com/customisation/1095

info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Left Appendage Occlusion Device Market Size Soars: Projected 21.2% CAGR Growth by 2031 here

News-ID: 3549540 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

White Spirit : Market Size, Share Drivers and opportunities, Market Analysis, Prominent Players, Massive CAGR, Challenges And Segmentations, Regional Study and Forecast by 2031
White Spirit : Market Size, Share Drivers and opportunities, Market Analysis, Pr …
The Global White Spirit Market Size is estimated to be $7.21 billion in 2023 and is expected to increase to $12.09 billion by 2031, with a compound annual growth rate (CAGR) of 6.88% during the forecast period of 2024-2031. Download Free Sample Pages @ https://www.insightaceanalytic.com/request-sample/1528 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global White Spirit Market are: • Growing demand in the paint and coatings industry • Increasing industrial applications • Rising construction activities Future expansion
Wellness Tourism : Market Analysis Report, Share, Size, Prominent Players, Current Scenario, Challenges and Segmentations , Regional Study Forecast by 2031
Wellness Tourism : Market Analysis Report, Share, Size, Prominent Players, Curre …
The Global Wellness Tourism Market Size is estimated to be 909.82 billion in 2023 and is expected to grow to 1974.18 billion by 2031, with a compound annual growth rate (CAGR) of 10.37% during the forecast period of 2024-2031. Download Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1603 The term "wellness tourism" denotes travel experiences that contribute to improving and enhancing one's physical, mental, and spiritual well-being. Tourists engage in a variety of activities, including yoga,
Global Vascular Access Device : Market Share Size, Major Players, Massive CAGR Development And Business Strategies, Collaborations and Segmentations Regional Study and Forecast 2028
Global Vascular Access Device : Market Share Size, Major Players, Massive CAGR D …
As per the most recent research conducted by Insightace Analytics, the global vascular access device market was valued at US$ 3,744.2 million in 2019. In the 2020-2028 forecast period, it is anticipated to expand at a compound annual growth rate (CAGR) of 5.9%. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1161 VADs are employed for diagnostic procedures, including the measurement of central venous pressure, the administration of fluids, the collection of blood samples, the
Water Treatment Chemicals : Market Size, Share, Prominent Players, Market Drivers, Challenges, Developments and Market Segmentations , Regional Study Forecast By 2031
Water Treatment Chemicals : Market Size, Share, Prominent Players, Market Driver …
The Global Water Treatment Chemicals Market Size is estimated to be 35.58 billion in 2023 and is expected to increase to 51.52 billion by 2031, with a compound annual growth rate (CAGR) of 4.50% during the forecast period of 2024-2031. Download Free Sample Pages : https://www.insightaceanalytic.com/request-sample/1617 Chemicals employed in wastewater treatment are classified as wastewater treatment chemicals. Sludge conditioners, defoamers, coagulants, and filter additives are among them. They are suitable for a

All 5 Releases


More Releases for Left

CHERRY Launches the MW 4500 LEFT for Left-Handed Users
KENOSHA, WIS., March 16, 2021 – Cherry Americas, part of the global leader in computer input devices, today announced the release of its new wireless mouse, the MW 4500 LEFT. This ergonomic mouse is designed with functional features for left-handed users and serves as an optimal tool for providing wrist relief in the office and home office. Best Ergonomics Now Also for Left-Handers With the MW 4500 LEFT, CHERRY brings
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Left Ventricular Dysfunction - Pipeline Review, H2 2016
Summary Global Markets Directs, Left Ventricular Dysfunction - Pipeline Review, H2 2016, provides an overview of the Left Ventricular Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Left Ventricular Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development
Right Brain-Left Brain Connections in Autistic Kids
August 23, 2013: Behavioral scientists know that an ability to process "non-verbal" signals lays the foundation for developing both language and social skills. Dr. Yola Barbosa , a director at a Brain Balance Achievement Center in New Jersey notes, "The ability to process the non-verbal communication lays the foundation of social skills and language. Kids with autism and even ADHD have a kind of social injury. They may
Lots of Life Left in 2 & 3G
ELECTRONICS.CA PUBLICATIONS, the electronics industry market research and knowledge network, announces the availability of a new report entitled "Global 3G Market Review". These days mobile broadband talk is all about LTE, WiMAX and 4G. These topics dominate discussions at trade shows and coverage in trade publications. It is as if 3G is on its death knell and 2G but a distant memory. When looking at the facts however the reality of